The 60 rating InvestorsObserver gives to Pieris Pharmaceuticals Inc (PIRS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 72 percent of stocks in the Biotechnology industry, PIRS’s 60 overall rating means the stock scores better than 60 percent of all stocks.
PIRS has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on PIRS!